BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29674492)

  • 1. 11
    Yang X; Hua W; Ryu S; Yates P; Chang C; Zhang H; Di L
    Drug Metab Dispos; 2018 Jul; 46(7):1023-1029. PubMed ID: 29674492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of threohydrobupropion from bupropion is dependent on 11β-hydroxysteroid dehydrogenase 1.
    Meyer A; Vuorinen A; Zielinska AE; Strajhar P; Lavery GG; Schuster D; Odermatt A
    Drug Metab Dispos; 2013 Sep; 41(9):1671-8. PubMed ID: 23804523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Main metabolic pathways of TAK-802, a novel drug candidate for voiding dysfunction, in humans: the involvement of carbonyl reduction by 11β-hydroxysteroid dehydrogenase 1.
    Nishihara M; Takahashi J; Kondo T; Mouri K; Asahi S
    Drug Res (Stuttg); 2014 Sep; 64(9):476-84. PubMed ID: 24357138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manifold effects of palmitoylcarnitine on endoplasmic reticulum metabolism: 11β-hydroxysteroid dehydrogenase 1, flux through hexose-6-phosphate dehydrogenase and NADPH concentration.
    Wang X; Mick GJ; Maser E; McCormick K
    Biochem J; 2011 Jul; 437(1):109-15. PubMed ID: 21492096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of adamantyl ethanone derivatives as potent 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors.
    Su X; Pradaux-Caggiano F; Thomas MP; Szeto MW; Halem HA; Culler MD; Vicker N; Potter BV
    ChemMedChem; 2010 Jul; 5(7):1026-44. PubMed ID: 20486152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of microsomal 11beta-HSD1 activity by cytosolic compounds: glutathione and hexose phosphoesters.
    McCormick KL; Wang X; Mick GJ
    J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):18-23. PubMed ID: 18550363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Coupling Determines the Activity: Comparison of 11β-Hydroxysteroid Dehydrogenase 1 and Its Coupling between Liver Parenchymal Cells and Testicular Leydig Cells.
    Li X; Hu G; Li X; Wang YY; Hu YY; Zhou H; Latif SA; Morris DJ; Chu Y; Zheng Z; Ge RS
    PLoS One; 2015; 10(11):e0141767. PubMed ID: 26528718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cyclicsulfonamide derivatives with an acetamide group as 11β-hydroxysteroid dehydrogenase 1 inhibitors.
    Kim SH; Kwon SW; Chu SY; Lee JH; Narsaiah B; Kim CH; Kang SK; Kang NS; Rhee SD; Bae MA; Ahn SH; Ha DC; Kim KY; Ahn JH
    Chem Pharm Bull (Tokyo); 2011; 59(1):46-52. PubMed ID: 21212546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
    Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
    J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11Beta-hydroxysteroid dehydrogenase type 1: purification from human liver and characterization as carbonyl reductase of xenobiotics.
    Maser E; Wsol V; Martin HJ
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):34-7. PubMed ID: 16343739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
    Baudrand R; Domínguez JM; Carvajal CA; Riquelme A; Campino C; Macchiavello S; Bozinovic M; Morales M; Pizarro M; Solis N; Escalona A; Boza C; Arrese M; Fardella CE
    Metabolism; 2011 Dec; 60(12):1775-80. PubMed ID: 21704348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499.
    Byun SY; Shin YJ; Nam KY; Hong SP; Ahn SK
    Life Sci; 2015 Jan; 120():1-7. PubMed ID: 25447448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11β-Hydroxysteroid dehydrogenase 1: Regeneration of active glucocorticoids is only part of the story.
    Odermatt A; Klusonova P
    J Steroid Biochem Mol Biol; 2015 Jul; 151():85-92. PubMed ID: 25151952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of pyridyl sulfonamide 11-beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors for the treatment of metabolic disorders.
    Yoon DS; Wu SC; Seethala R; Golla R; Nayeem A; Everlof JG; Gordon DA; Hamann LG; Robl JA
    Bioorg Med Chem Lett; 2014 Nov; 24(21):5045-9. PubMed ID: 25266782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 11beta-Hydroxysteroid dehydrogenase 1 reductase activity is dependent on a high ratio of NADPH/NADP(+) and is stimulated by extracellular glucose.
    Dzyakanchuk AA; Balázs Z; Nashev LG; Amrein KE; Odermatt A
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):137-41. PubMed ID: 18778749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationship of 2-adamantylmethyl tetrazoles as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1).
    Ye XY; Yoon D; Chen SY; Nayeem A; Golla R; Seethala R; Wang M; Harper T; Sleczka BG; Apedo A; Li YX; He B; Kirby M; Gordon DA; Robl JA
    Bioorg Med Chem Lett; 2014 Jan; 24(2):654-60. PubMed ID: 24360604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genistein inhibits glucocorticoid amplification in adipose tissue by suppression of 11β-hydroxysteroid dehydrogenase type 1.
    Tagawa N; Kubota S; Kobayashi Y; Kato I
    Steroids; 2015 Jan; 93():77-86. PubMed ID: 25447798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?
    Anagnostis P; Katsiki N; Adamidou F; Athyros VG; Karagiannis A; Kita M; Mikhailidis DP
    Metabolism; 2013 Jan; 62(1):21-33. PubMed ID: 22652056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microsomal enzyme 17β-hydroxysteroid dehydrogenase 3 faces the cytoplasm and uses NADPH generated by glucose-6-phosphate dehydrogenase.
    Legeza B; Balázs Z; Nashev LG; Odermatt A
    Endocrinology; 2013 Jan; 154(1):205-13. PubMed ID: 23183177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human and rat 11β-hydroxysteroid dehydrogenases activities by bisphenol A.
    Guo J; Yuan X; Qiu L; Zhu W; Wang C; Hu G; Chu Y; Ye L; Xu Y; Ge RS
    Toxicol Lett; 2012 Nov; 215(2):126-30. PubMed ID: 23069880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.